RESOURCES FROM THEWELL BIOSCIENCE

Harnessing Patient-Derived Organoids to Decode Immunotherapy Responses in Colorectal Cancer

The team from TheWell Bioscience has published a research highlight reporting research findings from Fondazione Policlinico A. Gemelli IRCCS.

References:

1. Esposito, A., Agostini, A., Quero, G. et al. Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance. Cell Death Dis 15, 878 (2024). https://doi.org/10.1038/s41419-024-07266-5

2. “Harnessing Patient-Derived Organoids to Decode Immunotherapy Responses in Colorectal Cancer. ” TheWell Bioscience, 12 Feb. 2025, https://www.thewellbio.com/research-highlights/harnessing-patient-derived-organoids-to-decode-immunotherapy-responses-in-crc/

*All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.